Flow Cytometry for TIL Analysis: Panel Design, Protocol & Marker Selection

Flow cytometry is the gold standard for high-dimensional phenotyping of tumor-infiltrating lymphocytes (TILs), enabling researchers to characterize immune cell composition, activation states, and exhaustion profiles at the single-cell level. For a complete overview of the tumor microenvironment and its cell populations, see our TME guide.

Practical Guide

Core TIL panel (8-color minimum): CD45 (immune gate), CD3 (T cells), CD4 (helper), CD8 (cytotoxic), CD19/CD20 (B cells), CD56 (NK cells), CD14 (monocytes), Viability dye. This panel provides the basic immune composition of the tumor. For fluorochrome selection and spectral overlap minimization, see our conjugate guide.

T cell exhaustion panel (add to core): PD-1, LAG-3, TIM-3, TIGIT, CD39 (ENTPD1). Co-expression of 2+ inhibitory receptors on CD8+ T cells defines exhaustion depth. TCF1/TCF7 (intracellular) distinguishes progenitor exhausted (TCF1+PD-1+) from terminally exhausted (TCF1-PD-1+TIM-3+) subsets.

Treg identification: CD4+CD25highFoxp3+ (intracellular staining required for Foxp3 — see our blocking and permeabilization guide for saponin-based ICS protocols). Add CD127 (low on Tregs), CTLA-4, GITR, Helios for further characterization. Treg frequency in the tumor correlates with immunosuppression in many cancer types.

Myeloid panel: CD11b, CD33, HLA-DR, CD14, CD15, CD16, CD68, CD163, CD206. Multi-marker gating is essential for MDSC identification (CD11b+CD33+HLA-DR-/low). TAM polarization: M1 (CD80+CD86+iNOS+) vs. M2 (CD163+CD206+ARG1+).

Functional analysis: Add intracellular staining for IFN-γ, TNF-α, Granzyme B, IL-2 after ex vivo restimulation (PMA/ionomycin or tumor antigen peptides) to assess T cell effector function within the TIL population. For cytokine biology context, see our cytokines guide. For proper gating with isotype and FMO controls, see our controls guide.

Technical notes: tumor tissue must be dissociated into single-cell suspension (enzymatic digestion with collagenase/DNase). Dead cell exclusion is critical (use amine-reactive viability dyes, not PI/DAPI, for fixed samples). Process tissue within 2–4 hours of resection for optimal viability. For complementary tissue-based profiling, multiplex IHC/IF preserves spatial context that flow cytometry cannot capture.

References

1. Cossarizza A, Chang HD, Radbruch A, et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition). Eur J Immunol. 2021;51(12):2708-3145. doi: 10.1002/eji.202170126

2. Binnewies M, Roberts EW, Kersten K, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541-550. doi: 10.1038/s41591-018-0014-x

3. Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252-264. doi: 10.1038/nrc3239

All products are for research use only. For technical support, contact order@abinscience.com.